πŸ‡ΊπŸ‡Έ FDA
Patent

US 11807682

M971 chimeric antigen receptors

granted A61KA61K2239/31A61K40/11

Quick answer

US patent 11807682 (M971 chimeric antigen receptors) held by The United States of America, as represented by the Secretary, Department of Heath and Human Services expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Heath and Human Services
Grant date
Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2239/31, A61K40/11, A61K40/31, A61K40/4211